Testosterone as a protective factor against atherosclerosis--immunomodulation and influence upon plaque development...

Area of Science:

• Cardiovascular Medicine
• Immunology
• Endocrinology

Background:

• Inflammation, mediated by cytokines, is central to coronary atheroma development and rupture.
• Cytokine-induced inflammation can lead to plaque instability, vascular smooth muscle apoptosis, and thrombus formation, causing myocardial infarction.
• Cardiovascular disease risk is elevated in men with low testosterone levels.

Purpose of the Study:

• To explore the role of testosterone in inhibiting atheroma formation and progression.
• To investigate the hypothesis linking testosterone deficiency to increased risk of coronary artery disease.
• To discuss the immune-modulating effects of testosterone in the context of cardiovascular disease.

Main Methods:

• Review of recent studies on inflammation, cytokines, and cardiovascular disease.
• Examination of the immune-modulating effects of sex hormones, particularly testosterone.
• Discussion of the proposed mechanisms connecting testosterone deficiency to atheroma.

Main Results:

• Testosterone exhibits immune-modulating properties, suppressing pro-inflammatory cytokine activation.
• Low testosterone levels are associated with increased risk of coronary artery disease.
• Physiological testosterone levels may exert an anti-inflammatory effect crucial for atheroprotection.

Conclusions:

• Testosterone's anti-inflammatory actions may be vital in preventing or slowing coronary atheroma progression.
• Testosterone deficiency could be a significant factor in atheroma formation and acute coronary syndromes.
• Targeting testosterone's immune-modulating effects presents a potential therapeutic avenue for cardiovascular disease.